🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/05/1991 | 18,51 | 18,89 | 18,51 | 18,69 | +0,97% | 2,04% | 6.111.936 |
| 06/05/1991 | 18,25 | 18,57 | 18,19 | 18,51 | +0,87% | 2,07% | 3.843.226 |
| 03/05/1991 | 17,91 | 18,37 | 17,89 | 18,35 | +2,21% | 2,66% | 3.581.016 |
| 02/05/1991 | 17,81 | 17,97 | 17,81 | 17,95 | +1,23% | 0,89% | 5.007.763 |
| 01/05/1991 | 17,22 | 17,73 | 17,16 | 17,73 | +3,48% | 3,35% | 4.927.277 |
| 30/04/1991 | 17,26 | 17,33 | 17,10 | 17,14 | +0,00% | 1,38% | 4.869.427 |
| 29/04/1991 | 17,37 | 17,57 | 17,08 | 17,14 | -1,15% | 2,86% | 4.421.722 |
| 26/04/1991 | 17,29 | 17,47 | 17,24 | 17,33 | -0,57% | 1,38% | 2.932.723 |
| 25/04/1991 | 17,33 | 17,51 | 17,22 | 17,43 | +0,34% | 1,72% | 3.857.688 |
| 24/04/1991 | 17,49 | 17,53 | 17,26 | 17,37 | -0,57% | 1,59% | 4.134.989 |
| 23/04/1991 | 17,53 | 17,55 | 17,33 | 17,47 | +0,00% | 1,25% | 3.088.666 |
| 22/04/1991 | 17,57 | 17,63 | 17,41 | 17,47 | -1,01% | 1,24% | 4.356.326 |
| 19/04/1991 | 17,85 | 17,97 | 17,65 | 17,65 | -2,31% | 1,78% | 6.975.907 |
| 18/04/1991 | 18,13 | 18,19 | 17,99 | 18,07 | -0,98% | 1,10% | 2.794.387 |
| 17/04/1991 | 17,95 | 18,41 | 17,93 | 18,25 | +1,55% | 2,66% | 4.858.738 |
| 16/04/1991 | 17,49 | 17,97 | 17,43 | 17,97 | +3,08% | 3,07% | 4.942.997 |
| 15/04/1991 | 17,29 | 17,47 | 17,28 | 17,43 | +1,04% | 1,15% | 2.823.941 |
| 12/04/1991 | 17,31 | 17,37 | 17,14 | 17,26 | +0,23% | 1,38% | 2.700.067 |
| 11/04/1991 | 17,04 | 17,33 | 17,04 | 17,22 | +1,52% | 1,75% | 2.551.670 |
| 10/04/1991 | 16,94 | 17,04 | 16,86 | 16,96 | +0,00% | 1,06% | 2.487.533 |
| 09/04/1991 | 17,18 | 17,28 | 16,92 | 16,96 | -1,27% | 2,08% | 3.184.872 |
| 08/04/1991 | 16,98 | 17,29 | 16,94 | 17,18 | +1,17% | 2,11% | 2.416.478 |
| 05/04/1991 | 17,29 | 17,35 | 16,88 | 16,98 | -1,50% | 2,76% | 3.725.640 |
| 04/04/1991 | 17,26 | 17,45 | 17,12 | 17,24 | -0,12% | 1,96% | 3.423.816 |
| 03/04/1991 | 17,35 | 17,41 | 17,24 | 17,26 | -0,23% | 1,03% | 3.596.736 |
| 02/04/1991 | 16,86 | 17,29 | 16,84 | 17,29 | +3,08% | 2,71% | 2.848.464 |
| 01/04/1991 | 16,70 | 16,78 | 16,64 | 16,78 | +0,00% | 0,83% | 3.264.101 |
| 28/03/1991 | 16,96 | 16,98 | 16,74 | 16,78 | -1,06% | 1,41% | 1.998.326 |
| 27/03/1991 | 17,24 | 17,28 | 16,86 | 16,96 | -1,39% | 2,42% | 3.924.341 |
| 26/03/1991 | 16,58 | 17,20 | 16,56 | 17,20 | +3,59% | 3,84% | 4.080.912 |